goralatide has been researched along with Thrombocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aidoudi, S; Caen, JP; Guigon, M; Han, ZC; Lebeurier, I | 1 |
| Guest, I; Uetrecht, J | 1 |
1 review(s) available for goralatide and Thrombocytopenia
| Article | Year |
|---|---|
Bone marrow stem cell protection from chemotherapy by low--molecular-weight compounds.
Topics: Amifostine; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Cells; Ethylenes; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Leukopenia; MEDLINE; Molecular Weight; Oligopeptides; Pyrrolidonecarboxylic Acid; Thrombocytopenia | 2001 |
1 other study(ies) available for goralatide and Thrombocytopenia
| Article | Year |
|---|---|
In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil.
Topics: Animals; Fluorouracil; Hematopoiesis; Hematopoietic Stem Cells; Hemoglobins; Leukocyte Count; Male; Megakaryocytes; Mice; Mice, Inbred BALB C; Oligopeptides; Platelet Factor 4; Thrombocytopenia | 1996 |